ATE535212T1 - Implantierbare vorrichtung zur arzneimittelabgabe und für verbesserte sichtbarkeit - Google Patents

Implantierbare vorrichtung zur arzneimittelabgabe und für verbesserte sichtbarkeit

Info

Publication number
ATE535212T1
ATE535212T1 AT05753133T AT05753133T ATE535212T1 AT E535212 T1 ATE535212 T1 AT E535212T1 AT 05753133 T AT05753133 T AT 05753133T AT 05753133 T AT05753133 T AT 05753133T AT E535212 T1 ATE535212 T1 AT E535212T1
Authority
AT
Austria
Prior art keywords
implantable device
drug delivery
improved visibility
therapeutic agent
type
Prior art date
Application number
AT05753133T
Other languages
English (en)
Inventor
Bernhard Frohwitter
Original Assignee
J A C C Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J A C C Gmbh filed Critical J A C C Gmbh
Application granted granted Critical
Publication of ATE535212T1 publication Critical patent/ATE535212T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/07—Stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/003—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0032—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in radiographic density
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0035—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in release or diffusion time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0043—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in electric properties, e.g. in electrical conductivity, in galvanic properties
    • A61F2250/0045—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in electric properties, e.g. in electrical conductivity, in galvanic properties differing in electromagnetical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
  • Electrotherapy Devices (AREA)
AT05753133T 2004-06-09 2005-06-09 Implantierbare vorrichtung zur arzneimittelabgabe und für verbesserte sichtbarkeit ATE535212T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04013671A EP1604697A1 (de) 2004-06-09 2004-06-09 Implantierbare Vorrichtung
PCT/EP2005/006223 WO2005120393A2 (en) 2004-06-09 2005-06-09 Implantable device for drug delivery and improved visibility

Publications (1)

Publication Number Publication Date
ATE535212T1 true ATE535212T1 (de) 2011-12-15

Family

ID=34925321

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05753133T ATE535212T1 (de) 2004-06-09 2005-06-09 Implantierbare vorrichtung zur arzneimittelabgabe und für verbesserte sichtbarkeit

Country Status (5)

Country Link
US (1) US20090149947A1 (de)
EP (2) EP1604697A1 (de)
JP (1) JP2008501456A (de)
AT (1) ATE535212T1 (de)
WO (1) WO2005120393A2 (de)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250058B1 (en) 2000-03-24 2007-07-31 Abbott Cardiovascular Systems Inc. Radiopaque intraluminal stent
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US8740973B2 (en) * 2001-10-26 2014-06-03 Icon Medical Corp. Polymer biodegradable medical device
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US20060002968A1 (en) * 2004-06-30 2006-01-05 Gordon Stewart Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
EP1771132B1 (de) 2004-02-03 2019-03-27 V-Wave Ltd. Vorrichtung und verfahren zur steuerung von in-vivo-druck
US8998973B2 (en) 2004-03-02 2015-04-07 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8591568B2 (en) 2004-03-02 2013-11-26 Boston Scientific Scimed, Inc. Medical devices including metallic films and methods for making same
US7901447B2 (en) 2004-12-29 2011-03-08 Boston Scientific Scimed, Inc. Medical devices including a metallic film and at least one filament
US8632580B2 (en) 2004-12-29 2014-01-21 Boston Scientific Scimed, Inc. Flexible medical devices including metallic films
US8992592B2 (en) 2004-12-29 2015-03-31 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8709469B2 (en) 2004-06-30 2014-04-29 Abbott Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US11207457B2 (en) * 2004-08-27 2021-12-28 Edwards Lifesciences Corporation Device and method for establishing an artificial arterio-venous fistula
US8926545B2 (en) * 2004-08-27 2015-01-06 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
WO2006050106A1 (en) * 2004-10-28 2006-05-11 Microchips, Inc. Orthopedic and dental implant devices providing controlled drug delivery
WO2006110197A2 (en) 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
CA2602050C (en) 2005-03-11 2013-12-03 Wake Forest University Health Sciences Production of tissue engineered heart valves
US20060204445A1 (en) * 2005-03-11 2006-09-14 Anthony Atala Cell scaffold matrices with image contrast agents
WO2006099372A2 (en) 2005-03-11 2006-09-21 Wake Forest University Health Sciences Tissue engineered blood vessels
US20060204539A1 (en) 2005-03-11 2006-09-14 Anthony Atala Electrospun cell matrices
WO2006099332A2 (en) 2005-03-11 2006-09-21 Wake Forest University Health Sciences Production of tissue engineered digits and limbs
US7854760B2 (en) 2005-05-16 2010-12-21 Boston Scientific Scimed, Inc. Medical devices including metallic films
WO2007083288A2 (en) 2006-01-23 2007-07-26 Atria Medical Inc. Heart anchor device
US20070191816A1 (en) * 2006-02-13 2007-08-16 Boston Scientific Scimed, Inc. Radio frequency induced drug elution
EP1834606B1 (de) * 2006-03-16 2013-04-24 CID S.p.A. Stents
US8911496B2 (en) 2006-07-11 2014-12-16 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
DE102006038235A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Verbesserung der Stabilität biodegradierbarer metallischer Stents, Verfahren und Verwendung
EP2436682A1 (de) 2007-08-30 2012-04-04 Vertex Pharmceuticals Incorporated Kokristalle und pharmazeutische Zusammensetzungen damit
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
WO2009097468A2 (en) 2008-01-29 2009-08-06 Kliman Gilbert H Drug delivery devices, kits and methods therefor
DE102008002395A1 (de) * 2008-06-12 2009-12-17 Biotronik Vi Patent Ag Wirkstoffbeladenes Implantat
BRPI0910198A2 (pt) * 2008-06-30 2016-01-12 Silenseed Ltd composição para administração a partir de um sítio local de um agente baseado em nucleotídeos e método para tratar um sujeito sofrendo de uma doença requerendo tratamento local com um agente baseado em nucleotídeo.
US7951193B2 (en) 2008-07-23 2011-05-31 Boston Scientific Scimed, Inc. Drug-eluting stent
EP2358309B1 (de) 2008-12-18 2015-09-09 4-web Spine, Inc. Gerippeimplantat
US12279964B2 (en) 2008-12-18 2025-04-22 4Web, Llc Implants having bone growth promoting agents and methods of using such implants to repair bone structures
DE102009006941B4 (de) * 2009-01-30 2013-01-10 Otto Bock Healthcare Gmbh Verwendung von fein verteilten Metallpartikeln in einem Material, einer Hautauflage und einem orthopädischen Artikel
US9636255B2 (en) 2009-02-13 2017-05-02 Dose Medical Corporation Uveoscleral drug delivery implant and methods for implanting the same
US12186176B2 (en) 2009-05-04 2025-01-07 V-Wave Ltd. Shunt for redistributing atrial blood volume
US12453626B2 (en) 2009-05-04 2025-10-28 V-Wave Ltd. Shunt for redistributing atrial blood volume
WO2010128501A1 (en) 2009-05-04 2010-11-11 V-Wave Ltd. Device and method for regulating pressure in a heart chamber
US9034034B2 (en) 2010-12-22 2015-05-19 V-Wave Ltd. Devices for reducing left atrial pressure, and methods of making and using same
JP5937004B2 (ja) 2009-05-18 2016-06-22 ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 薬剤溶出眼内インプラント
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
WO2011028358A2 (en) * 2009-09-02 2011-03-10 Mayo Foundation For Medical Education And Research System and method for detecting healing adjacent to implanted medical device
US9566147B2 (en) 2010-11-17 2017-02-14 Abbott Cardiovascular Systems, Inc. Radiopaque intraluminal stents comprising cobalt-based alloys containing one or more platinum group metals, refractory metals, or combinations thereof
US11298251B2 (en) 2010-11-17 2022-04-12 Abbott Cardiovascular Systems, Inc. Radiopaque intraluminal stents comprising cobalt-based alloys with primarily single-phase supersaturated tungsten content
US9668915B2 (en) 2010-11-24 2017-06-06 Dose Medical Corporation Drug eluting ocular implant
US9238133B2 (en) 2011-05-09 2016-01-19 The Invention Science Fund I, Llc Method, device and system for modulating an activity of brown adipose tissue in a vertebrate subject
US9011510B2 (en) 2011-05-09 2015-04-21 The Invention Science Fund I, Llc Method, device and system for modulating an activity of brown adipose tissue in a vertebrate subject
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
US9724494B2 (en) 2011-06-29 2017-08-08 Abbott Cardiovascular Systems, Inc. Guide wire device including a solderable linear elastic nickel-titanium distal end section and methods of preparation therefor
US11135054B2 (en) 2011-07-28 2021-10-05 V-Wave Ltd. Interatrial shunts having biodegradable material, and methods of making and using same
US12115071B2 (en) 2012-09-25 2024-10-15 4Web, Llc Programmable intramedullary implants and methods of using programmable intramedullary implants to repair bone structures
US10143574B2 (en) * 2013-03-14 2018-12-04 Vactronix Scientific, Llc Monolithic medical devices, methods of making and using the same
WO2014144188A1 (en) * 2013-03-15 2014-09-18 Cook Medical Technologies Llc Drug eluting graft constructs and methods
US10517759B2 (en) 2013-03-15 2019-12-31 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
CN105555204B (zh) 2013-05-21 2018-07-10 V-波有限责任公司 用于递送减小左房压力的装置的设备
CN103463675B (zh) * 2013-08-23 2014-10-08 广州军区广州总医院 一种抗菌抗肿瘤骨科植入材料及其制备方法
US10092679B2 (en) 2013-10-18 2018-10-09 Wake Forest University Health Sciences Laminous vascular constructs combining cell sheet engineering and electrospinning technologies
WO2015073704A1 (en) 2013-11-13 2015-05-21 Covidien Lp Galvanically assisted attachment of medical devices to thrombus
JP2017086094A (ja) * 2014-03-17 2017-05-25 テルモ株式会社 ステント
AU2015266850B2 (en) 2014-05-29 2019-12-05 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10265515B2 (en) 2015-03-27 2019-04-23 Covidien Lp Galvanically assisted aneurysm treatment
US10940296B2 (en) 2015-05-07 2021-03-09 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Temporary interatrial shunts
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
CN105251055B (zh) * 2015-11-17 2018-06-22 广西中医药大学 利用铱配合物提高二氧化钛纳米管的抗菌抗癌性能的方法
CN105457087B (zh) * 2015-11-17 2018-06-29 广西中医药大学 铱配合物修饰的钛金属材料及其制备方法和用途
CN105327391B (zh) * 2015-11-17 2018-06-22 广西中医药大学 利用铱配合物制备具有抗菌抗癌的二氧化钛纳米管的方法
CN105288753B (zh) * 2015-11-17 2018-06-22 广西中医药大学 姜黄素衍生物修饰的钛金属材料及其制备方法和用途
CN105288723B (zh) * 2015-11-17 2018-06-22 广西中医药大学 利用铱配合物处理二氧化钛纳米管的方法
CN105288745B (zh) * 2015-11-17 2018-06-22 广西中医药大学 具有抗菌抗癌的二氧化钛纳米管的制备方法
CN105412991B (zh) * 2015-11-17 2018-06-29 广西中医药大学 姜黄素衍生物修饰的聚乙烯材料及其制备方法与用途
CN105288726B (zh) * 2015-11-17 2018-06-22 广西中医药大学 钌配合物修饰的钛金属材料及其制备方法和用途
CN105412982B (zh) * 2015-11-17 2018-06-22 广西中医药大学 一种提高二氧化钛纳米管抗菌和抗癌作用的方法
CN105457089B (zh) * 2015-11-20 2018-04-03 广西中医药大学 一种具有抗菌抗癌性能的钛金属的制备方法
CN105457088B (zh) * 2015-11-20 2018-04-03 广西中医药大学 一种制备具有抗菌抗癌性能的钛金属的方法
CN105288724B (zh) * 2015-11-20 2018-04-06 广西中医药大学 利用姜黄素衍生物处理二氧化钛纳米管的方法
CA3022830A1 (en) 2016-04-20 2017-10-26 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device
US10835394B2 (en) 2016-05-31 2020-11-17 V-Wave, Ltd. Systems and methods for making encapsulated hourglass shaped stents
US20170340460A1 (en) 2016-05-31 2017-11-30 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
DE102016110199A1 (de) * 2016-06-02 2017-12-07 Phenox Gmbh Vasospasmusbehandlung
US11096781B2 (en) 2016-08-01 2021-08-24 Edwards Lifesciences Corporation Prosthetic heart valve
AU2017371223B2 (en) 2016-12-09 2023-04-27 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
US20180325651A1 (en) * 2017-05-10 2018-11-15 Cook Medical Technologies Llc Self-adapting graft for patients
CN109717876B (zh) * 2017-10-31 2023-12-26 心脏起搏器股份公司 用于化学传感器的结构式扩散隔膜
US10898698B1 (en) 2020-05-04 2021-01-26 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US11458287B2 (en) 2018-01-20 2022-10-04 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
EP3740163A1 (de) 2018-01-20 2020-11-25 V-Wave Ltd. Vorrichtungen und verfahren zur bereitstellung eines durchgangs zwischen herzkammern
CN107998108A (zh) * 2018-01-24 2018-05-08 北京航空航天大学 一种利用可降解金属颗粒控制药物释放的复合材料
CN113395931A (zh) 2018-12-12 2021-09-14 爱德华兹生命科学公司 集成压力感测的心脏植入装置
EP3917587B1 (de) * 2019-01-30 2026-06-03 Biotronik Ag Bedeckter stent zur lokalen arzneistoffabgabe
CN109876198A (zh) * 2019-03-18 2019-06-14 吉林大学中日联谊医院 一种心血管支架
EP3714914A1 (de) * 2019-03-29 2020-09-30 Picosun Oy Federbelastete medizinische vorrichtung
US12226602B2 (en) 2019-04-03 2025-02-18 V-Wave Ltd. Systems for delivering implantable devices across an atrial septum
US11612385B2 (en) 2019-04-03 2023-03-28 V-Wave Ltd. Systems and methods for delivering implantable devices across an atrial septum
WO2020219265A1 (en) 2019-04-22 2020-10-29 Edwards Lifesciences Corporation Anchor for transcatheter access into the coronary sinus
WO2020217194A1 (en) * 2019-04-25 2020-10-29 V-Wave Ltd. Interatrial shunts having biodegradable material, and methods of making and using same
WO2020234751A1 (en) 2019-05-20 2020-11-26 V-Wave Ltd. Systems and methods for creating an interatrial shunt
JP2022536362A (ja) 2019-06-12 2022-08-15 エドワーズ ライフサイエンシーズ コーポレイション 左心房圧管理のための流体バイパス導管
CN122297046A (zh) 2019-08-22 2026-06-30 爱德华兹生命科学公司 穿刺针
JP7528198B2 (ja) 2019-09-19 2024-08-05 エドワーズ ライフサイエンシーズ コーポレイション 経カテーテル穿刺針システム
US12151049B2 (en) 2019-10-14 2024-11-26 Abbott Cardiovascular Systems, Inc. Methods for manufacturing radiopaque intraluminal stents comprising cobalt-based alloys with supersaturated tungsten content
CN114727836B (zh) 2019-11-14 2026-01-09 爱德华兹生命科学公司 经导管的医疗植入物递送
US12102535B2 (en) 2019-11-15 2024-10-01 4Web, Llc Piezoelectric coated implants and methods of using piezoelectric coated implants to repair bone structures
CA3156685A1 (en) 2019-11-19 2021-05-27 Zenflow, Inc. SYSTEMS, DEVICES AND METHODS FOR ACCURATE DEPLOYMENT AND IMAGING OF AN IMPLANT IN THE PROSTATIC URETHRA
CN111358605A (zh) * 2020-03-20 2020-07-03 贾伟 一种髂静脉支架
AU2021244477B2 (en) 2020-03-23 2026-03-12 4Web, Inc. Sacroiliac joint fusion systems and methods
US12599756B2 (en) 2020-05-04 2026-04-14 V-Wave Ltd. Devices with dimensions that can be reduced and increased In Vivo
WO2022011173A1 (en) * 2020-07-08 2022-01-13 4Web, Inc. Implants having bone growth promoting agents contained within biodegradable materials
AU2024204010B2 (en) * 2020-07-08 2026-02-12 4Web, Inc. Implants having bone growth promoting agents contained within biodegradable materials
CA3199943A1 (en) 2020-08-24 2022-03-03 Edwards Lifesciences Corporation Balloon cover for a delivery apparatus for an expandable prosthetic heart valve
CN112336500A (zh) * 2020-11-13 2021-02-09 山东瑞安泰医疗技术有限公司 一种可溶性多微针的药物支架
US11234702B1 (en) 2020-11-13 2022-02-01 V-Wave Ltd. Interatrial shunt having physiologic sensor
WO2022133070A1 (en) 2020-12-18 2022-06-23 Edwards Lifesciences Corporation Flexible shunt implants
US12527942B2 (en) 2021-02-01 2026-01-20 Edwards Lifesciences Corporation Pulmonary vein shunting
CN112972769B (zh) * 2021-02-20 2023-02-03 西北有色金属研究院 一种金属表面制备含纳米银抗菌肽功能涂层的方法
IL308303A (en) 2021-05-21 2024-01-01 Edwards Lifesciences Corp I will secure a conducting catheter in the coronary sinus using a mechanical release arm
US11813386B2 (en) 2022-04-14 2023-11-14 V-Wave Ltd. Interatrial shunt with expanded neck region
CN115813603A (zh) * 2022-11-22 2023-03-21 台州恩泽医疗中心(集团) 一种十二指肠开窗支架
CN116059013B (zh) * 2023-03-29 2023-06-23 中国人民解放军联勤保障部队第九二〇医院 用于植入髌骨关节的可吸收囊式间隔器及其制造方法
WO2025083586A1 (en) 2023-10-18 2025-04-24 V-Wave Ltd. Hybrid devices with dimensions that can be adjusted in vivo and methods of manufacturing thereof
USD1137672S1 (en) 2024-08-27 2026-07-28 Glaukos Corporation Drug eluting ocular implant

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290271A (en) * 1990-05-14 1994-03-01 Jernberg Gary R Surgical implant and method for controlled release of chemotherapeutic agents
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CA2380683C (en) 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5599352A (en) 1992-03-19 1997-02-04 Medtronic, Inc. Method of making a drug eluting stent
DE4222380A1 (de) * 1992-07-08 1994-01-13 Ernst Peter Prof Dr M Strecker In den Körper eines Patienten perkutan implantierbare Endoprothese
EP0604022A1 (de) * 1992-12-22 1994-06-29 Advanced Cardiovascular Systems, Inc. Mehrschichtiges resorbierbares Stent und Verfahren zu dessen Herstellung
AU7476894A (en) 1993-07-29 1995-02-28 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
AU699821B2 (en) * 1994-10-17 1998-12-17 Kabushikikaisha Igaki Iryo Sekkei Stent for liberating drug
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
ZA9710342B (en) * 1996-11-25 1998-06-10 Alza Corp Directional drug delivery stent and method of use.
ES2251073T3 (es) * 1997-02-20 2006-04-16 Cook Incorporated Dispositivo medico implantable dotado de un revestimiento.
US6240616B1 (en) * 1997-04-15 2001-06-05 Advanced Cardiovascular Systems, Inc. Method of manufacturing a medicated porous metal prosthesis
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7208010B2 (en) * 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
EP0966979B1 (de) 1998-06-25 2006-03-08 Biotronik AG Implantierbare, bioresorbierbare Gefässwandstütze, insbesondere Koronarstent
US7018401B1 (en) * 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6737447B1 (en) 1999-10-08 2004-05-18 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
US7250058B1 (en) * 2000-03-24 2007-07-31 Abbott Cardiovascular Systems Inc. Radiopaque intraluminal stent
US8252044B1 (en) * 2000-11-17 2012-08-28 Advanced Bio Prosthestic Surfaces, Ltd. Device for in vivo delivery of bioactive agents and method of manufacture thereof
WO2002026281A1 (en) * 2000-09-29 2002-04-04 Cordis Corporation Coated medical devices
WO2002026109A2 (en) * 2000-09-29 2002-04-04 Endovasc Ltd., Inc. Resorbable prosthesis for medical treatment
WO2003061502A1 (en) * 2000-10-26 2003-07-31 Scimed Life Systems, Inc. Stent having radiopaque markers and method of fabricating the same
US20010044650A1 (en) * 2001-01-12 2001-11-22 Simso Eric J. Stent for in-stent restenosis
DE60115192T2 (de) * 2001-02-26 2006-08-10 Ethicon, Inc. Bioverträglicher Verbundschaum
ATE330564T1 (de) 2001-07-20 2006-07-15 Sorin Biomedica Cardio Srl Stent
US20030088307A1 (en) * 2001-11-05 2003-05-08 Shulze John E. Potent coatings for stents
DE20200220U1 (de) * 2002-01-08 2002-03-21 Translumina Gmbh Stent
AU2003221677A1 (en) * 2002-04-11 2003-10-27 Secant Medical, Inc. Covering process using electrospinning of very small fibers
JP2004033579A (ja) * 2002-07-05 2004-02-05 Medicos Hirata:Kk 生体吸収性ステント及びその製造方法

Also Published As

Publication number Publication date
US20090149947A1 (en) 2009-06-11
EP1765220B1 (de) 2011-11-30
WO2005120393A2 (en) 2005-12-22
JP2008501456A (ja) 2008-01-24
EP1604697A1 (de) 2005-12-14
EP1765220A2 (de) 2007-03-28
WO2005120393A3 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
WO2005120393A3 (en) Implantable device for drug delivery and improved visibility
MX2007002189A (es) Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
AU2002312254A8 (en) Tbc1d1s as modifiers of the p53 pathway and methods of use
ATE406179T1 (de) Sauerstoff-abgabe mittel und ihre anwendung
MX364408B (es) Aparatos y metodos para suministrar agentes terapeuticos.
BRPI0519047A2 (pt) mÉtodo para a produÇço de um agente de contraste marcador ou agente terapÊutico marcador, agentes de contraste marcadores e uso de agentes de contraste marcadores ou de agentes terapÊuticos marcadores
TW200505402A (en) Ophthalmic drug delivery device
DE602005013490D1 (de) Missbrauchsichere transdermale abgabevorrichtung für opioide, enthaltend opioidantagonist in form von mikrokügelchen
CO5611160A2 (es) Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos
DE60329729D1 (de) Implantierbare Vorrichtung zur Arzneimittelverabreichung
WO2007089435A3 (en) Medical devices for therapeutic agent delivery
BR0210335A (pt) Copolìmero de blocos, e, composição
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
AU2003288977A8 (en) Transdermal delivery of fentanyl
TW200501969A (en) Ophthalmic compositions containing a synergistic combination of three polymers
ATE484257T1 (de) System zur zuführung von dentalen werkstoffen
AU2003276656A8 (en) Transdermal delivery system for anti-emetic medication
MX362908B (es) Implantes que contienen fármacos y métodos de uso de los mismos.
HRP20080569T3 (en) Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin
ATE423578T1 (de) Medizinprodukt mit einem biologischen wirkstoff
BRPI0508865B8 (pt) dispositivo de liberação de medicamento visível por raio x
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
WO2005010148A3 (en) Marks as modifiers of the pten pathway and methods of use
DE69904020D1 (de) Pharmazeutische zusammensetzung zur nasalen verabreichung von thiocolchicosid